Pre-made Lutetium (177Lu) Lilotomab Satetraxetan benchmark antibody (Radiolabelled antibody, anti-CD37 therapeutic antibody, Anti-GP52-40/TSPAN26 Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-INN-904

Pre-made Lutetium (177Lu) Lilotomab Satetraxetan benchmark antibody (Radiolabelled antibody, anti-CD37 therapeutic antibody, Anti-GP52-40/TSPAN26 Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.



Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-INN-904-1mg 1mg 3090
GMP-Bios-INN-904-10mg 10mg Inquiry
GMP-Bios-INN-904-100mg 100mg Inquiry
GMP-Bios-INN-904-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Lutetium (177Lu) Lilotomab Satetraxetan Biosimilar, Radiolabelled Antibody, Anti-Cd37 Antibody: Anti-GP52-40/TSPAN26 therapeutic antibody
INN Name Lutetium (177Lu) Lilotomab Satetraxetan
TargetCD37
FormatRadiolabelled antibody
DerivationMus musculus
Species Reactivityhuman
CH1 IsotypeIgG1 - kappa
VD LCIgG1 - kappa
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
CompaniesNordic Nanovector ASA (Oslo Norway)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech0